The FDA granted the Pfizer-BioNTech coronavirus vaccine full approval in a highly anticipated move that’s expected to boost vaccinations and spark more mandates nationwide, the New York Times reports.
The decision will set off a cascade of vaccine requirements by hospitals, colleges, corporations and other organizations.

Save to Favorites
